A Phase II Study to Evaluate the Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients Receiving Dose-Dense Doxorubicin/Cyclophosphamide

PURPOSE: Dose-dense chemotherapy (DD-CT) is a preferred (neo)adjuvant regimen in early breast cancer (BC). Although the results of reported randomized trials are conflicting, a recent metaanalysis showed improved overall and disease-free survival with DD-CT compared to conventional schedules. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Gun Min, Kim, Joo Hoon, Kim, Ji Heung, Cho, Young Up, Kim, Seung Il, Park, Seho, Park, Hyung Seok, Kim, Ji Ye, Sohn, Joohyuk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473288/
https://www.ncbi.nlm.nih.gov/pubmed/30235921
http://dx.doi.org/10.4143/crt.2018.383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473288/
https://www.ncbi.nlm.nih.gov/pubmed/30235921
http://dx.doi.org/10.4143/crt.2018.383

Ejemplares similares